Brief: Biocartis Announces Expansion Of Its Collaboration With Apis Assay Technologies
12/10/2023 06:08
Oct 12 (Reuters) - Biocartis Group NV BCART.BR :
* APIS ESR1 MUTATIONS KIT IS A QUALITATIVE, QPCR10 BASED,
RUO
PRODUCT FOR DETECTION OF ESR1 MUTATIONS IN PLASMA SAMPLES
* ANNOUNCES EXPANSION OF ITS COLLABORATION WITH APIS ASSAY
TECHNOLOGIES TO COMMERCIALIZE APIS ESR1 MUTATIONS KIT
Source text for Eikon: ID:nGNEcd7CxQ
Further company coverage: BCART.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Biocartis NV
See all newsBrief: Biocartis Group NV Appoints Randy Polonsky As Chief Financial Officer
Brief: Biocartis Appoints New Chief Business Officer, VP Global Marketing
Brief: Biocartis And Merck To Collaborate
Brief: Biocartis's Secured Creditors Enforced Their Security Over Subsidiaries Shares
Brief: Biocartis Announces Expansion Of Its Collaboration With Apis Assay Technologies